Point-counterpoint: Cervical cancer screening should be done by primary human papillomavirus testing with genotyping and reflex cytology for women over the age of 25 years

Journal of Clinical Microbiology

Volumn 53, Issue 9, 2015, Pages 2798-2804

  Stoler, Mark H ^a   Austin, R Marshall ^b   Zhao, Chengquan ^b  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; ALGORITHM; ARTICLE; CANCER RISK; CANCER SCREENING; COLPOSCOPY; COMPARATIVE EFFECTIVENESS; CYTOLOGY; DIAGNOSTIC TEST APPROVAL; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS DNA TEST; PAPANICOLAOU TEST; PATIENT SAFETY; PREDICTIVE VALUE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX CANCER; ADULT; AGED; FEMALE; GENOTYPING TECHNIQUE; MASS SCREENING; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PATHOLOGY; PROCEDURES; UNITED STATES; UTERINE CERVICAL NEOPLASMS; VERY ELDERLY; VIROLOGY;

HUMAN PAPILLOMAVIRUS;

ADULT; AGED; AGED, 80 AND OVER; COLPOSCOPY; CYTOLOGICAL TECHNIQUES; FEMALE; GENOTYPING TECHNIQUES; HUMANS; MASS SCREENING; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; UNITED STATES; UTERINE CERVICAL NEOPLASMS;

EID: 84940092732     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01087-15     Document Type: Article

References (23)

1. FDA. 12 March 2014. Meeting materials of the microbiology devices panel. FDA, Bethesda, MD. http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/MedicalDevices/Medical DevicesAdvisoryCommittee/MicrobiologyDevicesPanel/UCM388564/pdf.
2. Rositch AF, Nowak RG, Gravitt PE. 2014. Increased age and race-specific incidence of cervical cancer after correction for hysterectomy prevalence in the United States from 2000 to 2009. Cancer 120:2032-2038. http://dx/doi.org/10.1002/cncr.28548.
3. Bouchard-Fortier G, Hajifathalian K, McKnight MD, Zacharias DG, Gonzalez-Gonzalez LA. 2014. Co-testing for detection of high-grade cervical intraepithelial neoplasia and cancer compared with cytology alone: a meta-analysis of randomized controlled trials. J Public Health 36:46-55. http://dx.doi.org/10.1093/pubmed/fdt057.
4. Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain J, Garcia FA, Moriarty AT, Waxman AG, Wilbur DC, Wentzensen N, Downs LS, Jr, Spitzer M, Moscicki AB, Franco EL, Stoler MH, Schiffman M, Castle PE, Myers ER, American Cancer Society, American Society for Colposcopy and Cervical Pathology, American Society for Clinical Pathology. 2012. Screening guidelines for the prevention and early detection of cervical cancer.AmJ Clin Pathol 137:516-542. http://dx/doi.org/10.1309/AJCPTGD94EVRSJCG.
5. Belinson J, Qiao YL, Pretorius R, Zhang WH, Elson P, Li L, Pan QJ, Fischer C, Lorincz A, Zahniser D. 2001. Shanxi Province Cervical Cancer Screening Study: a cross-sectional comparative trial of multiple techniques to detect cervical neoplasia. Gynecol Oncol 83:439-444. http://dx/doi.org/10.1006/gyno.2001.6370.
6. Zhao C, Florea A, Onisko A, Austin RM. 2009. Histologic follow-up results in 662 patients with Pap test findings of atypical glandular cells: results from a large academic women's hospital laboratory employing sensitive screening methods. Gynecol Oncol 114:383-389. http://dx.doi.org/10.1016/j.ygyno.2009.05.019.
7. Dudding N, Crossley J. 2013. Sensitivity and specificity of HPV testing: what are the facts? Cytopathology 24:283-288. http://onlinelibrary.wiley/com/doi/10.1111/cyt.12104/abstr.
8. Kitchener HC, Almonte M, Gilham C, Dowie R, Stoykova B, Sargent A, Roberts C, Desai M, Peto J, ARTISTIC Trial Study Group. 2009. ARTISTIC: a randomised trial of human papillomavirus (HPV) testing in primary cervical screening. Health Technol Assess 13:1-150. http://www/journalslibrary.nihr.ac.uk/hta/volume-13/issue-51.
9. McCrory DB, Matchar DB, Bastian L, Datta S, Hasselblad V, Hickey J, Myers E, Nanda K. 1999. Evaluation of cervical cytology. Evidence Report/ Technology Assessment no. 5. AHCPR Publication no. 99-E010. Agency for Health Care Policy and Research, Rockville, MD. http://www/ncbi.nlm.nih.gov/books/NBK11840/
10. Dillner J, Rebolj M, Birembaut P, Petry KU, Szarewski A, Munk C, de Sanjose S, Naucler P, Lloveras B, Kjaer S, Cuzick J, van Ballegooijen M, Clavel C, Iftner T, Joint European Cohort Study. 2008. Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study. BMJ 337:a1754. http://dx/doi.org/10.1136/bmj.a1754.
11. Vesco KK, Whitlock EP, Eder M, Lin J, Burda BU, Senger CA, Holmes RS, Fu R, Zuber S. 2011. Screening for cervical cancer. A systematic evidence review for the U.S. Preventive Services Task Force. Evidence Synthesis, no. 86. AHRQ Publication no. 11-05156-EF-1. Oregon Evidence-Based Practice Center, Portland, OR. http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0016542/pdf/TOC.pdf.
12. McCredie MR, Sharples KJ, Paul C, Baranyai J, Medley G, Jones RW, Skegg DC. 2008. Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. Lancet Oncol 9:425-434. http://dx.doi.org/10.1016/S1470/2045(08)70103-7.
13. Kinney W, Fetterman B, Poltras N, Lorey T. 2014. CIN3- is not the right endpoint for evaluating screening algorithms, as it does not reflect cancer risk accurately. Gynecol Oncol 133S:186. http://www.gynecologiconcology/online.net/article/S0090-8258(14)00730-6/abstr.
14. Ronco G, Dillner J, Elfström KM, Tunesi S, Snijders PJ, Arbyn M, Kitchener H, Segnan N, Gilham C, Giorgi-Rossi P, Berkhof J, Peto J, Meijer CJ, International HPV Screening Working Group. 2014. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials. Lancet 383:524-532. http://dx.doi.org/10.1016/S0140-6736(13)62218-7.
15. Katki HA, Kinney WK, Fetterman B, Lorey T, Poitras NE, Cheung L, Demuth F, Schiffman M, Wacholder S, Castle PE. 2011. Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice. Lancet Oncol 12:663-672. http://dx.doi.org/10.1016/S1470-2045(11)70145-0.
16. Gage JC, Schiffman M, Katki HA, Castle PE, Fetterman B, Wentzensen N, Poitras NE, Lorey T, Cheung LC, Kinney WK. 2014. Reassurance against future risk of precancer and cancer conferred by a negative human papillomavirus test. J Natl Cancer Inst 106:1-4. http://jnci.oxfordjournals/org/content/106/8/dju153.full.pdf.html.
17. Kinney W, Wright TC, Dinkelspiel HE, DeFrancesco M, Cox TJ, Huh W. 2015. Increased cervical cancer risk with screening at longer intervals. Obstet Gynecol 125:311-315. http://dx.doi.org/10.1097/AOG.0000000000000632.
18. Gross CP. 2014. Cancer screening in older persons. A new age of wonder. JAMA Intern Med 174:1565-1567. http://dx.doi.org/10.1001/jamainternmed.2014.3901.
19. CDC Newsroom. 5 November 2014. Millions of US women are not getting screened for cervical cancer. CDC, Atlanta, GA. http://www.cdc.gov/media/releases/2014/p1105-vs-cervical-cancer.html.
20. Health Council of the Netherlands. 2011. Population screening for cervical cancer. Health Council of the Netherlands, the Hague, the Netherlands. Publication no. 2011/07. http://www.gezondheidsraad.nl/sites/default/files/summaryBHMK.pdf.
21. Australian Government Medical Services Advisory Committee. 2014. Application no. 1276. Renewal of the National Cervical Screening Program. Australian Government Medical Services Advisory Committee, Canberra, Australia. http://www.cancerscreening.gov.au/internet/screening/publishing.nsf/Content/ncsp/renewal.
22. Wu Y, Chen Y, Li L, Yu G, Zhang Y, He Y. 2006. Associations of high-risk HPV types and viral load with cervical cancer in China. J Clin Virol 35:264-269.
23. Zhao C, Li Z, Nayar R, Levi AW, Winkler BA, Moriarty AT, Barkan GA, Rao J, Miller F, Fan F, Zhou Z, Si Q, Fischer AH, Sturgis CD, Jing X, Marshall CB, Witt BL, Birdsong GG, Crothers BA. 2015. Prior high-risk human papillomavirus testing and Papanicolaou test results of 70 invasive cervical carcinomas diagnosed in 2012: results of a retrospective multicenter study. Arch Pathol Lab Med 139:184-188. http://dx.doi.org/10.5858/arpa.2014-0028-OA.